Biotechnology

Techseriesinsight > Blog > News > Biotechnology

July 5, 2023
tsi_admin
Biotechnology

Biocomposites invests in Renovos Biologics – developers of the RENOVITE® nanoclay therapeutic delivery platform

Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for regenerating bone and managing infection in bone and soft tissue, today announces it has...

June 21, 2023
PRNewswire
Biotechnology

Exact Sciences Advances Innovative Cancer Technologies and Approaches Through Visionary Collaborations

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced separate collaborations with two renowned healthcare organizations at the forefront of cancer research. The...

June 21, 2023
PRNewswire
Artificial Intelligence, Biotechnology

Nuvilab Awarded as 2023 Technology Pioneer by World Economic Forum

Amidst the escalating global concern surrounding food & nutrition insecurity and inequality, a remarkable surge of corporate initiatives has emerged, aiming to combat the prevailing issue of food circularity....

June 19, 2023
PRNewswire
Artificial Intelligence, Biotechnology

Delta4 Identifies a Potential New Therapeutic Option for Focal Segmental Glomerulosclerosis (FSGS) using computational Hyper-C Drug Discovery Platform

Delta4, a pioneering digital drug discovery company specializing in identifying new therapeutic indications for drugs with established safety profiles, has made a promising breakthrough in the search for novel...

June 6, 2023
PRNewswire
Biotechnology

The combination of ISA101b and Libtayo® shows promising results in patients whose head and neck cancer progressed on anti-PD1 therapy

ISA Pharmaceuticals B.V., a clinical-stage biotechnology company developing immunotherapies to treat cancers and serious infectious diseases, presented the first clinical data of the combination of ISA101b (peltopepimut-S) and Regeneron’s anti-PD-1...

May 31, 2023
Business Wire
Biotechnology

New Preclinical Data on AI-Generated Target Identified in BenevolentAI and AstraZeneca Collaboration Presented at ATS 2023

BenevolentAI (Euronext Amsterdam: BAI), a leader that combines cutting-edge Artificial Intelligence (AI) and science to accelerate biopharma discovery and development, announces that AstraZeneca presented new preclinical data on an...

May 22, 2023
PRNewswire
Biotechnology

A.Menarini Diagnostics announces the release of the PRIME MDx platform

A.Menarini Diagnostics S.r.l. is pleased to announce the commercial launch of its PRIME MDx platform: a sample-to-result, all-in-one, fully-automated molecular diagnostics platform for the processing of various testing portfolios through...

May 18, 2023
PRNewswire
Biotechnology

GenScript Expands Peptide and Oligonucleotide Production Facility in China

GenScript Biotech Corporation, the world’s leading provider of life-science research tools and services, has expanded its primary manufacturing facility for oligonucleotide and peptide production at Zhenjiang, Jiangsu, China. The expansion...

May 17, 2023
PRNewswire
Artificial Intelligence, Biotechnology

New Clarivate Biopharma Dealmaking Report Reveals Investment Patterns Set to Impact the Future of Medicine

Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its new report, Biopharma Dealmaking in 2023. This year’s...

May 17, 2023
PRNewswire
Artificial Intelligence, Biotechnology

With a CAGR of 28.4%, Artificial Intelligence in Breast Imaging Market to Grow Exponentially by 2029 – Brandessence Market Research

Breast cancer has emerged as one of the most dreadful diseases occurring mostly in women. So far, this ailment has claimed millions of lives. Proper screening and diagnosis of...